236 
Market Cap
Stock Chart
ResMed - 30 Day Poll
Recent BLOGS About ResMed Add New
Latest Company News
|
Forget The Facebook Generation -- There's A Bigger Investing Opportunity With ...
Forbes - May 18, 2012 Many of us boomers aren't sleeping that well. That is an opportunity for ResMed. Entrepreneur Victor Kiam became famous for his advertising slogan, “I liked the shaver so much, I bought the company.
Forget The Facebook Generation -- And Revisit The Boomers - TheStreet.com |
|
Stocks to watch Friday: Osiris, Autodesk, Marvell
MarketWatch - May 18, 2012 By MarketWatch WASHINGTON (MarketWatch) - Among the stocks that could see active trade in Friday's session are Osiris Therapeutics Inc., Autodesk Inc. and Marvell Technology Group Ltd.
|
|
ResMed hunting for new CEO
Australian Life Scientist - May 18, 2012 ResMed (ASX:RMD) is hunting internally and externally for a new CEO to replace founter Dr Peter Farrell when he steps down as CEO at the end of 2013.
|
|
Stocks to watch at close on Friday
Sydney Morning Herald - May 18, 2012 AAP Stocks to watch on the Australian stock exchange at close on Friday: MYR - MYER HOLDINGS LTD - down 10 cents at $2.15 A dearth of customers and heavy discounting are expected to have kept Myer's sales in the doldrums.
|
|
ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive ...
MarketWatch (press release) - May 17, 2012 SAN DIEGO, May 17, 2012 /PRNewswire via COMTEX/ -- ResMed Inc. (NYSE:RMD) today announced plans to initiate a dividend beginning in fiscal year 2013.
|
|
ResMed Inc. Plans To Initiate Dividend And Announces Chief Executive Officer Succession
Reuters Key Development - May 17, 2012 |
|
9 High-Growth Healthcare Stocks With Strong Inventory Trends
Seeking Alpha - May 17, 2012 Do you consider a stock's sales trends when comparing names? For ideas on how to start your own sales analysis, we ran a screen.
|
|
Strap On The CPAP And Sleep Easy With ResMed
Forbes - May 15, 2012 ResMed (RMD - Snapshot Report) sees 2013 earnings increases and has recently become a Zacks #1 Rank (Strong Buy). ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, ...
|
Website
Videos related to ResMed
Company Profile
ResMed (NYSE: RMD and ASX: RMD) is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing (SDB) and other respiratory disorders. ResMed operates in over 68 countries via 18 direct offices and a network of distributors with extensive knowledge and experience of local markets.
ResMed's device for treating obstructive sleep apnea (OSA), a major subset of SDBaddresses nasal continuous positive airway pressure (CPAP) and provided the first successful noninvasive treatment of OSA. SDB affects around 20% of the adult population, making it as widespread as diabetes or asthma. However, awareness is low and we believe that about 90% of people who have OSA remain undiagnosed and untreated.
The term “sleep-disordered breathing” includes a spectrum of respiratory disorders ranging in severity from snoring to OSA. OSA occurs when the airway temporarily collapses during sleep, preventing or restricting breathing for up to ten seconds or more. Such events can occur several hundred times a night severely disrupting sleep.
Financial snapshot:
Resmed said its net profit for the three months to September 30 was $US50.5 million ($A48.35 million), down from $US56.7 million ($A54.28 million) in the previous corresponding period.
The company continues to invest approximately 6% of revenues in research and product development.